Edition:
United States

Medical Equipment, Supplies & Distribution

Page 1

Spineway confirms 2018 sales-revenue goal of about 10 million euros​

12:00pm EST

Nov 22 (Reuters) - SPINEWAY SAS ::CONFIRM 2018 SALES-REVENUE GOAL OF APPROXIMATELY EUR 10M​.NO LONGER WISHES TO COMMUNICATE ON ‍REACHING FINANCIAL EQUILIBRIUM FOR 2018 FY.

Dignitana appoints new CEO

6:45am EST

Nov 22 (Reuters) - DIGNITANA AB ::DIGNITANA APPOINTS WILLIAM CRONIN AS NEW CEO.‍CRONIN WILL TAKE ON CEO ROLE IN Q1 OF 2018.​.‍PRESENT CEO JOHAN ERICSSON WILL RESIGN WHEN WILLIAM CRONIN HAS TAKEN OVER IN Q1 OF 2018​.

Redsense Medical Q3 pretax loss at SEK 2.9 mln

2:45am EST

Nov 22 (Reuters) - REDSENSE MEDICAL AB (PUBL) ::Q3 REVENUE SEK ‍353,000 VERSUS SEK 722,000​.Q3 PRETAX LOSS SEK 2.9 MILLION VERSUS LOSS SEK 2.5 MILLION YEAR AGO‍​.

Bactiguard's endotracheal tubes approved in India

2:23am EST

Nov 22 (Reuters) - BACTIGUARD HOLDING AB ::BACTIGUARD'S ENDOTRACHEAL TUBES APPROVED IN INDIA.

Medicrea receives FDA clearance for IB3D 3d-printed titanium interbody devices

2:00am EST

Nov 22 (Reuters) - MEDICREA INTERNATIONAL SA ::MEDICREA RECEIVES FDA CLEARANCE FOR 3D-PRINTED TITANIUM INTERBODY DEVICES AND INTRODUCES ADAPTEK™ SURGEON-ADAPTIVE TECHNOLOGY.‍RECEIVES FDA CLEARANCE FOR ITS IB3D RANGE OF 3D-PRINTED TITANIUM INTERBODY DEVICES​.

Admedus ‍receives regulatory approval to launch Cardiocel product in India

Tuesday, 21 Nov 2017 07:48pm EST

Nov 22 (Reuters) - Admedus Ltd :‍Received regulatory approval to launch Cardiocel product in India.

Paragon Care sees FY18 revenue guidance of $125mln – $135mln‍​

Tuesday, 21 Nov 2017 06:34pm EST

Nov 22 (Reuters) - Paragon Care Ltd :Sees FY18 revenue guidance of $125 million – $135 million‍​.Sees FY18 EBITDA guidance of $18 million – $19 million.

Mimedx provides update on its reimbursement coverage

Tuesday, 21 Nov 2017 09:15am EST

Nov 21 (Reuters) - Mimedx Group Inc :Mimedx provides update on its reimbursement coverage.Mimedx Group Inc - ‍provided a reimbursement update in light of FDA final and draft guidance documents related to human tissue​.Mimedx Group Inc - "‍with issuance of final hct/p guidance document by FDA, we believe payer coverage for epifix will further improve"​.

Patterson Companies reports 2018 Q2 earnings $0.43/shr

Tuesday, 21 Nov 2017 07:00am EST

Nov 21 (Reuters) - Patterson Companies Inc :Patterson Companies reports fiscal 2018 second-quarter results.Sees FY 2018 adjusted non-GAAP earnings per share $2.00 to $2.10.Q2 adjusted earnings per share $0.51.Q2 GAAP earnings per share $0.43.Q2 sales $1.4 billion versus I/B/E/S view $1.42 billion.Q2 earnings per share view $0.54 -- Thomson Reuters I/B/E/S.Sees FY 2018 GAAP earnings per share $1.67 to $1.77.Patterson Companies - ‍adjusting for effects of currency translation, sales declined 2.8 percent in quarter.Patterson Companies Inc - ‍ negative impact to sales from recent hurricanes of approximately 60 basis points​ in quarter.Patterson Companies Inc - ‍negative impact from recent hurricanes of approximately $0.01 per diluted share in quarter​.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary